Juliette Humer is founder and CEO of Muse Bio, pioneering a new frontier in regenerative medicine by transforming menstrual blood into a globally scalable, affordable, and ethical source of stem cells. Inspired by her own recovery journey from a spinal injury in her early twenties, Juliette turned a deeply personal medical need into a bold vision—one that slashes the cost of 100 million stem cells from $100,000 to just $1,000 through non-invasive, at-home collection.

She brings a strong academic foundation in biochemistry and environmental health from Hampshire College, where she studied the intersection of toxicology and molecular biology.

In under a year, she’s raised $1.1M in pre‑seed funding from top-tier investors including Draper VC and Boost VC, built a world-class team, secured lab space, and joined leading biotech accelerators like Nucleate and Infinita. Muse Bio now supports over 1,000 people on its biobanking waitlist, has LOIs with more than a dozen biotech partners, and resonates with more than a million people across social platforms—especially women ready to reclaim agency in their healthcare.

At 30, Juliette isn’t just innovating in the lab—she’s creating the future supply chain of regenerative medicine, blending scientific rigor with system-level impact and a deeply personal mission.